These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15743913)

  • 41. Concerns voiced on Depo Provera.
    Sanders C
    RNAO News; 1986; 42(3):15, 22. PubMed ID: 2940668
    [No Abstract]   [Full Text] [Related]  

  • 42. Use of DMPA by adolescents.
    Gold MA; Hertweck SP; Lara-Torre E
    J Pediatr Adolesc Gynecol; 2005 Dec; 18(6):435-7. PubMed ID: 16338614
    [No Abstract]   [Full Text] [Related]  

  • 43. Contraceptive efficacy and safety of DMPA-SC.
    Jain J; Jakimiuk AJ; Bode FR; Ross D; Kaunitz AM
    Contraception; 2004 Oct; 70(4):269-75. PubMed ID: 15451329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bone mineral density and depot medroxyprogesterone acetate.
    Albertazzi P; Bottazzi M; Steel SA
    Contraception; 2006 Jun; 73(6):577-83. PubMed ID: 16730487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Contraception with Depo-Provera. Report of a series of 930 women].
    Mahjoub S; Lebbi I; Dakhli R; Smaïli L; Ben Hmjd R; Ben Romdhane M; Zouari F; Hamzaoui R
    Tunis Med; 2000 Nov; 78(11):662-6. PubMed ID: 11155390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Depo-Provera contraceptive may increase risk of cardiovascular disease.
    Bosch X
    BMJ; 2002 Sep; 325(7363):513. PubMed ID: 12219755
    [No Abstract]   [Full Text] [Related]  

  • 47. Depo-provera. A lesson in communication.
    Dennerstein G
    Aust Fam Physician; 1988 Mar; 17(3):176-8. PubMed ID: 2965569
    [No Abstract]   [Full Text] [Related]  

  • 48. Two recent studies find Depo-Provera use increases HIV risk.
    Harper KN
    AIDS; 2015 Jun; 29(9):N1. PubMed ID: 25870992
    [No Abstract]   [Full Text] [Related]  

  • 49. Bone loss associated with long-term use of depot medroxyprogesterone acetate.
    Lo SS; Fan SY;
    Hong Kong Med J; 2005 Dec; 11(6):491-5. PubMed ID: 16340026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Controversies in contraception.
    Pitts SA; Emans SJ
    Curr Opin Pediatr; 2008 Aug; 20(4):383-9. PubMed ID: 18622191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Depo-Provera public hearing.
    Dening FC
    Midwives Chron; 1983 Jul; 96(1146):246. PubMed ID: 6225940
    [No Abstract]   [Full Text] [Related]  

  • 52. Acute necrotic skin reaction to intramuscular Depo-Provera.
    Clark SM; Lanigan SW
    Br J Dermatol; 2000 Dec; 143(6):1356-7. PubMed ID: 11122072
    [No Abstract]   [Full Text] [Related]  

  • 53. FDA advisory panel recommends approval for Depo-Provera.
    Contracept Technol Update; 1992 Oct; 13(10):159-60. PubMed ID: 12344726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spinal bone density in women using depot medroxyprogesterone contraception.
    Szarewski A; Mansour D
    Obstet Gynecol; 1999 Apr; 93(4):629-30. PubMed ID: 10214848
    [No Abstract]   [Full Text] [Related]  

  • 55. Bone mineral density in women using depot medroxyprogesterone acetate (DMPA) for at least 2 years compared to a control group: a cross sectional study.
    Pongsatha S; Ekmahachai M; Chaovisitsaree S; Suntornlimsiri N; Morakote N
    J Med Assoc Thai; 2009 Oct; 92(10):1263-7. PubMed ID: 19845231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Women's responses to Depo-Provera.
    Freda MC; Abruzzo-Fogarassy M; Adams NV; Davini D; DeVore N; Merkatz IR
    MCN Am J Matern Child Nurs; 1996; 21(4):183-6. PubMed ID: 8754434
    [No Abstract]   [Full Text] [Related]  

  • 57. Update on Depo-Provera.
    Sapire KE
    S Afr Med J; 1992 May; 81(9):444-5. PubMed ID: 1533472
    [No Abstract]   [Full Text] [Related]  

  • 58. [Depo-Provera--antineoplastic agents which is also a contraceptive].
    Tylleskär J
    Jordemodern; 1988 Mar; 101(3):55-8. PubMed ID: 2967271
    [No Abstract]   [Full Text] [Related]  

  • 59. Depo-Provera: the jury still out.
    Gold RB
    Fam Plann Perspect; 1983; 15(2):78-81. PubMed ID: 6231191
    [No Abstract]   [Full Text] [Related]  

  • 60. [Experiences with Depo-Provera as a contraceptive agent].
    Kollstedt E; Sjöborg G
    Jordemodern; 1984; 97(1-2):18-20. PubMed ID: 6231273
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.